| 000 | 01621 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250511182740.0 | ||
| 264 | 0 | _c19921110 | |
| 008 | 199211s 0 0 eng d | ||
| 022 | _a0278-0232 | ||
| 024 | 7 |
_a10.1002/hon.2900100310 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKlein, S | |
| 245 | 0 | 0 |
_aIn vitro differentiation of a Hodgkin's disease derived cell line. _h[electronic resource] |
| 260 |
_bHematological oncology _c |
||
| 300 |
_a195-205 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aCD3 Complex _xanalysis |
| 650 | 0 | 4 |
_aCD4 Antigens _xanalysis |
| 650 | 0 | 4 |
_aCD8 Antigens _xanalysis |
| 650 | 0 | 4 |
_aCell Transformation, Neoplastic _xdrug effects |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFluorescent Antibody Technique |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 |
_aHodgkin Disease _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-2 _xanalysis |
| 650 | 0 | 4 |
_aInterleukin-3 _xanalysis |
| 650 | 0 | 4 |
_aInterleukin-4 _xanalysis |
| 650 | 0 | 4 |
_aInterleukin-8 _xanalysis |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 |
_aReceptors, Antigen, T-Cell, alpha-beta _xanalysis |
| 650 | 0 | 4 |
_aReceptors, Interleukin-2 _xanalysis |
| 650 | 0 | 4 |
_aT-Lymphocytes _xchemistry |
| 650 | 0 | 4 |
_aTetradecanoylphorbol Acetate _xpharmacology |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aJones, D B | |
| 700 | 1 | _aTesch, H | |
| 773 | 0 |
_tHematological oncology _gvol. 10 _gno. 3-4 _gp. 195-205 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/hon.2900100310 _zAvailable from publisher's website |
| 999 |
_c1405016 _d1405016 |
||